Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
McKinsey
Dow
AstraZeneca
Merck

Last Updated: May 24, 2022

PTAB Cases from Par Pharmaceutical, Inc.


✉ Email this page to a colleague

« Back to Dashboard

Patent Trial and Appeal Board Cases for Petitioner: Par Pharmaceutical, Inc.

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,665,772 Par Pharmaceutical, Inc. See Plans and Pricing 2015-10-26 10-26-2015 COTTENS et al Inter partes review See Plans and Pricing 04-29-2016 SYLVAIN COTTENS See Plans and Pricing
5,665,772 Par Pharmaceutical, Inc. See Plans and Pricing 2016-05-17 05-17-2016 Novartis AG Inter partes review See Plans and Pricing 10-27-2016 SYLVAIN COTTENS See Plans and Pricing
6,455,518 Par Pharmaceutical, Inc. See Plans and Pricing 2015-10-26 10-26-2015 Novartis AG Inter partes review See Plans and Pricing 04-28-2016 Gerhard Zenke See Plans and Pricing
7,297,703 Par Pharmaceutical, Inc. See Plans and Pricing 2015-10-26 10-26-2015 Novartis AG Inter partes review See Plans and Pricing 04-01-2016 Francois Navarro See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
AstraZeneca
McKesson
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.